Education
About Us
Working with TipRanks
Follow Us
Incyte Corp (INCY)
NASDAQ:INCY
Incb123667
Healthy Participants
Phase I
Recruiting
Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants
Oct 16, 2025
―
Povorcitinib
Hidradenitis Suppurativa (Hs)
Phase II
Not Yet Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Oct 07, 2025
―
Incb123667, Investigator's Choice Of Chemotherapy
Ovarian Cancer
Phase III
Not Yet Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Oct 06, 2025
―
Inca036873
Solid Tumors, Hematologic Malignancies
Phase I
Not Yet Recruiting
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Sep 19, 2025
―
Inca034176, Best Available Treatment (Bat)
Chronic Graft-Versus-Host-Disease
Phase II
Not Yet Recruiting
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Aug 08, 2025
―
Inca000585
Immune Thrombocytopenia
Phase II
Not Yet Recruiting
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Jul 29, 2025
―
ruxolitinib cream
Hidradenitis Suppurativa
Phase I
Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Jun 25, 2025
―
Incb000631
Healthy Participants
Phase I
Recruiting
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
Jun 18, 2025
―
Incb123667
Ovarian Cancer
Phase II
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Jun 09, 2025
―
Itraconazole, Famotidine, Esomeprazole, Rifampin, Incb161734
Healthy Participants
Phase I
Recruiting
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
Jun 04, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Incyte Corp (INCY) have in its pipeline
INCY is currently developing the following drugs: Incb123667, Povorcitinib, Incb123667, Investigator's Choice Of Chemotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.